Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
about
Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?Valproic acid-associated encephalopathyCarnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugsHyperammonemia associated with valproic acid concentrations.Valproic acid toxicity: overview and management.Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs.Hepatotoxicity to sodium valproate: a review.A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver.Carnitine in the treatment of valproic acid-induced toxicity.Carnitine, valproate, and toxicity.Use of precision-cut renal cortical slices in nephrotoxicity studies.Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.Valproate-associated hepatotoxicity and its biochemical mechanisms.The risk-benefit ratio of anticonvulsant drugs.Valproate-induced coma: case report and literature review.Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoANon-Hyperammonemic valproate encephalopathy.Characteristics of glutamine metabolism in human precision-cut kidney slices: a 13C-NMR study.Stuporous episodes during treatment with sodium valproate: report of seven cases.Effects of valproate and citrulline on ammonium-induced encephalopathy.Simultaneous side effects of both clozapine and valproate.Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.Protocols and Applications of Cellular Metabolomics in Safety Studies Using Precision-Cut Tissue Slices and Carbon 13 NMR.Effects of antiepileptic drugs and seizure type on operant responding in mentally retarded persons.
P2860
Q24813193-F1BBEA7B-E344-4D72-A027-FBA6C22E965AQ28331564-177BACFC-E2B7-4DE7-BB7A-C5432365950AQ28377394-31B6274B-A521-4005-BD52-60E0054F7AEDQ33608984-2227A3A5-2004-4E6A-9AF7-447E11D91735Q33963043-A8372E2A-F641-427F-B3B0-2BB6934D4996Q34447821-60A7486F-E6BF-47BD-AEC2-83CF6995D0B5Q34525582-A3C41D14-FFB1-40C6-B514-5B8FB3EEDCEDQ35968146-D837EE51-C67D-44D9-B28F-D6D861E76074Q37413086-6E1703CE-3292-4CE0-8765-1E6BF8A56B8EQ37659363-85ED01D9-C462-421D-8638-BCA5D5931489Q38048918-6C9DAF70-504B-4A96-A03D-67EE9B2CD8A5Q38682728-67094659-2EDF-4BD4-90D1-83E033B04DB2Q38861352-C0EE8F21-24B7-4442-80FE-92D1E8B12725Q39602947-E8ED4173-CAC2-49C2-A7B1-87920F285C8CQ39675361-77088DE0-5FD8-4FE9-840D-D6EED68300CEQ40832816-C9C1E8EE-4E0C-4C52-B1F2-8666ED3B9B8FQ41834447-473C9EA4-70AA-4F4F-85D6-839D01242B59Q42014438-02F3AB60-778C-4C74-A7CA-11C0C2D6DF51Q42141496-09FACCCF-ACB6-429E-8850-D0E433892410Q42258113-11386B11-48C1-44B8-849B-2A927ED1BF84Q42284685-FC666BC0-94A8-4B22-A851-21884FC245E3Q43656607-6AF0F429-0C98-46CE-A77B-41AE68E6AB6BQ44796480-E926B2F8-5B58-4CE8-A547-9D7C9563FB06Q47750040-11AC49EA-CB86-4480-8F13-EE7A9D0511AEQ49075329-E2E09BD5-52BF-429F-BA39-3CF2FAF2F348
P2860
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
@en
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
@nl
type
label
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
@en
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
@nl
prefLabel
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
@en
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
@nl
P1433
P1476
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
@en
P2093
D L Coulter
P304
P356
10.1016/S0140-6736(80)91773-0
P407
P577
1980-06-01T00:00:00Z